2020
DOI: 10.3390/metabo10060262
|View full text |Cite
|
Sign up to set email alerts
|

Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

Abstract: In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagnosis. We used ultra-performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight mass spectrometry operating in high energy collision spectral acquisition mode (MSE) mode (UPLC-QTOF-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 61 publications
0
12
0
Order By: Relevance
“…Following a method previously published by our group [ 47 ], untargeted LC-MS analysis was performed using an ACQUITY UPLC coupled to a XEVO-G2XS QTOF mass spectrometer (Waters, Manchester, UK). Liquid chromatography was performed using an Acquity UPLC CSHC18 column (2.1 × 100 mm, 1.7 mm, Waters).…”
Section: Methodsmentioning
confidence: 99%
“…Following a method previously published by our group [ 47 ], untargeted LC-MS analysis was performed using an ACQUITY UPLC coupled to a XEVO-G2XS QTOF mass spectrometer (Waters, Manchester, UK). Liquid chromatography was performed using an Acquity UPLC CSHC18 column (2.1 × 100 mm, 1.7 mm, Waters).…”
Section: Methodsmentioning
confidence: 99%
“…First, plasma plasmalogen levels could be used as a biomarker to indicate the onset of cellular dysfunction and monitor the rate and extent of the deterioration or improvement ( Fernandes et al, 2020 ). Detecting plasmalogens in the blood, for example, would be an advantage over other methods of detection ( Fernandes et al, 2020 ).…”
Section: Significance Of Studying the Effect Of Plasmalogen On Membrane Morphologymentioning
confidence: 99%
“…First, plasma plasmalogen levels could be used as a biomarker to indicate the onset of cellular dysfunction and monitor the rate and extent of the deterioration or improvement ( Fernandes et al, 2020 ). Detecting plasmalogens in the blood, for example, would be an advantage over other methods of detection ( Fernandes et al, 2020 ). Second, restoring plasmalogen levels (by oral supplements for example) at the appropriate intervention time could potentially delay or prevent the onset of cellular dysfunction that is associated with neurodegenerative and/or age-related diseases.…”
Section: Significance Of Studying the Effect Of Plasmalogen On Membrane Morphologymentioning
confidence: 99%
“…Epigenetic modification, such as MLH1 hypermethylation that results in a loss of mismatch repair methylation change, has been suggested as a longitudinal biomarker for CRC [ 11 ]. Moreover, lipid peroxidation and altered metabolites are currently considered a hallmark characteristic of CRC [ 12 , 13 , 14 ]. Therefore, genetic, epigenetic, and lipidic biomarkers are needed to provide new insights into CRC risk, development, and progression.…”
Section: Introductionmentioning
confidence: 99%